Clinical Trial Detail

NCT ID NCT01790568
Title Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors University of Michigan Cancer Center
Indications
Therapies

Methotrexate

Tacrolimus

Vorinostat

Age Groups: adult

No variant requirements are available.